TipRanks
Pharmicell Co., Ltd (KR:005690)
:005690
South Korea Market

Pharmicell Co., Ltd (005690) Ratios

Followers

Pharmicell Co., Ltd Ratios

KR:005690's free cash flow for Q2 2026 was ₩0.43. For the 2026 fiscal year, KR:005690's free cash flow was decreased by ₩ and operating cash flow was ₩0.34. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
7.15 4.92 6.28 5.56 2.18
Quick Ratio
6.01 4.11 3.70 2.87 1.38
Cash Ratio
0.94 1.47 1.08 1.77 0.50
Solvency Ratio
1.22 1.29 0.73 0.53 0.32
Operating Cash Flow Ratio
2.55 2.09 0.46 1.52 0.28
Short-Term Operating Cash Flow Coverage
6.59 6.84 13.52 4.84 0.47
Net Current Asset Value
₩ 74.01B₩ 63.08B₩ 35.21B₩ 31.04B₩ 29.38B
Leverage Ratios
Debt-to-Assets Ratio
0.14 0.09 <0.01 0.03 0.15
Debt-to-Equity Ratio
0.18 0.12 <0.01 0.04 0.22
Debt-to-Capital Ratio
0.15 0.11 <0.01 0.04 0.18
Long-Term Debt-to-Capital Ratio
0.12 0.06 0.00 0.00 0.00
Financial Leverage Ratio
1.28 1.27 1.15 1.15 1.47
Debt Service Coverage Ratio
6.47 6.89 26.37 2.20 0.64
Interest Coverage Ratio
45.00 232.55 45.93 1.10 11.89
Debt to Market Cap
0.04 0.02 <0.01 <0.01 0.03
Interest Debt Per Share
441.77 245.46 13.12 65.31 293.38
Net Debt to EBITDA
0.22 -0.39 -0.80 -1.27 0.28
Profitability Margins
Gross Profit Margin
44.08%43.85%32.89%26.60%39.58%
EBIT Margin
32.38%29.61%9.82%9.96%11.16%
EBITDA Margin
34.57%32.27%14.54%15.01%14.79%
Operating Profit Margin
32.38%29.61%7.18%1.69%14.74%
Pretax Profit Margin
34.54%30.52%9.66%8.42%9.92%
Net Profit Margin
34.26%35.36%9.76%6.36%13.73%
Continuous Operations Profit Margin
34.26%35.36%9.76%6.36%13.73%
Net Income Per EBT
99.19%115.86%101.07%75.61%138.41%
EBT Per EBIT
106.66%103.06%134.55%497.59%67.27%
Return on Assets (ROA)
25.29%25.62%6.38%3.87%7.33%
Return on Equity (ROE)
36.50%32.56%7.32%4.45%10.78%
Return on Capital Employed (ROCE)
26.19%24.51%5.08%1.12%10.54%
Return on Invested Capital (ROIC)
25.05%23.45%5.05%0.76%8.79%
Return on Tangible Assets
26.09%26.56%6.76%4.12%7.75%
Earnings Yield
7.23%4.62%1.27%0.96%1.28%
Efficiency Ratios
Receivables Turnover
4.48 5.24 3.87 7.16 5.00
Payables Turnover
16.58 21.74 14.11 23.23 13.69
Inventory Turnover
4.15 4.01 2.20 1.98 1.59
Fixed Asset Turnover
2.49 2.42 1.52 1.38 1.63
Asset Turnover
0.74 0.72 0.65 0.61 0.53
Working Capital Turnover Ratio
1.43 1.94 1.71 1.62 1.63
Cash Conversion Cycle
147.44 143.81 234.31 219.87 275.74
Days of Sales Outstanding
81.43 69.61 94.27 50.99 72.93
Days of Inventory Outstanding
88.03 90.99 165.90 184.59 229.47
Days of Payables Outstanding
22.02 16.79 25.86 15.71 26.66
Operating Cycle
169.46 160.60 260.17 235.58 302.40
Cash Flow Ratios
Operating Cash Flow Per Share
683.60 684.05 58.30 198.12 132.00
Free Cash Flow Per Share
435.24 559.87 -14.00 97.14 -184.18
CapEx Per Share
248.36 124.18 72.30 100.98 316.18
Free Cash Flow to Operating Cash Flow
0.64 0.82 -0.24 0.49 -1.40
Dividend Paid and CapEx Coverage Ratio
2.29 4.74 0.63 1.96 0.42
Capital Expenditure Coverage Ratio
2.75 5.51 0.81 1.96 0.42
Operating Cash Flow Coverage Ratio
1.61 2.81 5.10 3.90 0.47
Operating Cash Flow to Sales Ratio
0.30 0.36 0.05 0.21 0.13
Free Cash Flow Yield
4.05%3.85%-0.17%1.56%-1.71%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
14.00 21.62 78.48 103.83 78.02
Price-to-Sales (P/S) Ratio
4.79 7.65 7.66 6.61 10.71
Price-to-Book (P/B) Ratio
4.55 7.04 5.75 4.62 8.41
Price-to-Free Cash Flow (P/FCF) Ratio
24.95 25.95 -591.48 64.13 -58.37
Price-to-Operating Cash Flow Ratio
15.89 21.24 142.02 31.45 81.44
Price-to-Earnings Growth (PEG) Ratio
0.11 0.04 1.03 -1.84 -6.19
Price-to-Fair Value
4.55 7.04 5.75 4.62 8.41
Enterprise Value Multiple
14.09 23.30 51.89 42.75 72.70
Enterprise Value
654.93B 857.78B 489.26B 360.82B 647.03B
EV to EBITDA
13.94 23.30 51.89 42.75 72.70
EV to Sales
4.82 7.52 7.54 6.42 10.75
EV to Free Cash Flow
25.08 25.53 -582.46 62.29 -58.59
EV to Operating Cash Flow
15.97 20.89 139.86 30.54 81.75
Tangible Book Value Per Share
2.30K 1.97K 1.35K 1.25K 1.23K
Shareholders’ Equity Per Share
2.39K 2.06K 1.44K 1.35K 1.28K
Tax and Other Ratios
Effective Tax Rate
<0.01 -0.16 -0.01 0.24 -0.38
Revenue Per Share
2.27K 1.90K 1.08K 942.89 1.00K
Net Income Per Share
776.18 671.97 105.51 60.00 137.79
Tax Burden
0.99 1.16 1.01 0.76 1.38
Interest Burden
1.07 1.03 0.98 0.85 0.89
Research & Development to Revenue
0.05 0.06 0.12 0.12 0.11
SG&A to Revenue
0.07 0.03 0.05 0.05 0.04
Stock-Based Compensation to Revenue
<0.01 0.00 0.00 0.00 0.00
Income Quality
0.88 1.02 0.55 3.30 0.73
Currency in KRW